These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11962233)

  • 1. [A structure-activity study of a catalytic antiidiotypic antibody to the human erythrocyte acetylcholinesterase].
    Aleksandrova ES; Koralevski F; Titov MI; Demin AV; Kozyr' AV; Kolesnikov AV; Tramontano A; Paul S; Thomas D; Gabibov AG; Gnuchev NV; Friboulet A
    Bioorg Khim; 2002; 28(2):118-25. PubMed ID: 11962233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme mimicry by the antiidiotypic antibody approach.
    Kolesnikov AV; Kozyr AV; Alexandrova ES; Koralewski F; Demin AV; Titov MI; Avalle B; Tramontano A; Paul S; Thomas D; Gabibov AG; Friboulet A
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13526-31. PubMed ID: 11095704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity.
    Izadyar L; Friboulet A; Remy MH; Roseto A; Thomas D
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8876-80. PubMed ID: 8415624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic antibodies with acetylcholinesterase activity.
    Johnson G; Moore SW
    J Immunol Methods; 2002 Nov; 269(1-2):13-28. PubMed ID: 12379349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic mimicry of a catalytic antibody active site.
    Johnson G; Moore SW
    Mol Immunol; 2002 Oct; 39(5-6):273-88. PubMed ID: 12220886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiidiotypic antibodies exhibiting an acetylcholinesterase abzyme activity.
    Joron L; Izadyar L; Friboulet A; Remy MH; Pancino G; Roseto A; Thomas D
    Ann N Y Acad Sci; 1992 Nov; 672():216-23. PubMed ID: 1476371
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiidiotypic antibodies as functional internal images of enzyme-active sites.
    Friboulet A; Izadyar L; Avalle B; Roseto A; Thomas D
    Ann N Y Acad Sci; 1995 Mar; 750():265-70. PubMed ID: 7785852
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of pyridoxal 5'-phosphate dependent catalytic antibodies.
    Khomutov RM
    Biochemistry (Mosc); 2002 Oct; 67(10):1085-8. PubMed ID: 12460106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog.
    Guo J; Huang W; Zhou GW; Fletterick RJ; Scanlan TS
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1694-8. PubMed ID: 7878042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a novel adhesion-promoting site on acetylcholinesterase using catalytic antiacetylcholinesterase antibodies displaying cholinesterase-like activity.
    Johnson G; Moore SW
    Appl Biochem Biotechnol; 2000; 83(1-3):131-44; discussion 145-53. PubMed ID: 10826955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalysis of esterolytic reactions by the anti-idiotypic antibody against human erythrocyte acetylcholinesterase.
    Alexandrova ES; Koralewski F; Titov MI; Demin AV; Ignatova AN; Kozyr AV; Kolesnikov AV; Tramontano A; Paul S; Thomas D; Gabibov AG; Friboulet A
    Dokl Biochem Biophys; 2001; 377():75-8. PubMed ID: 11712155
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase-like catalytic antibodies: reaction with substrates and inhibitors.
    Johnson G; Moore SW
    Mol Immunol; 2000; 37(12-13):707-19. PubMed ID: 11275256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
    Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
    Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9.
    Chong LT; Bandyopadhyay P; Scanlan TS; Kuntz ID; Kollman PA
    J Comput Chem; 2003 Sep; 24(12):1371-7. PubMed ID: 12868101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalysis by anti-idiotypic antibodies.
    Avalle B; Friboulet A; Thomas D
    Chem Immunol; 2000; 77():80-8. PubMed ID: 11706707
    [No Abstract]   [Full Text] [Related]  

  • 19. Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
    Saxena A; Hur R; Doctor BP
    Biochemistry; 1998 Jan; 37(1):145-54. PubMed ID: 9425034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel allosteric sites on human erythrocyte acetylcholinesterase identified by two monoclonal antibodies.
    Olson CE; Chhajlani V; August JT; Schmell ED
    Arch Biochem Biophys; 1990 Mar; 277(2):361-7. PubMed ID: 1689985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.